Literature DB >> 17965566

Long-term survival with non-functioning pituitary carcinoma - case report - .

Junji Koyama1, Koji Ikeda, Yoshiteru Shose, Mitsuru Kimura, Yoshiro Obora, Eiji Kohmura.   

Abstract

A 35-year-old woman presented with a non-functioning pituitary adenoma manifesting as amenorrhea and impaired visual acuity in 1984. The tumor was grossly totally resected through a right frontotemporal craniotomy. The patient underwent surgery for three recurrences in the next 5 years. She was treated with gamma knife surgery for the residual tumor in 1994. Follow-up magnetic resonance (MR) imaging revealed a tumor in the right frontal base in 1999, and the left middle fossa in 2002. Total removal of these tumors was performed. Follow-up MR imaging showed regrowth of the primary pituitary tumor in 2003, which was partially excised. Histological examination of the specimens from the last three surgeries revealed typical pituitary adenoma without malignant transformation. Pituitary carcinomas have a poor prognosis. However, the present patient survived for 22 years from onset and 6 years from the first dural metastasis. Distant lesions should be removed for histological evaluation to assist the subsequent management.

Entities:  

Mesh:

Year:  2007        PMID: 17965566     DOI: 10.2176/nmc.47.475

Source DB:  PubMed          Journal:  Neurol Med Chir (Tokyo)        ISSN: 0470-8105            Impact factor:   1.742


  11 in total

Review 1.  Corticotrophic pituitary carcinoma with cervical metastases: case series and literature review.

Authors:  Frederick Yoo; Edward C Kuan; Anthony P Heaney; Marvin Bergsneider; Marilene B Wang
Journal:  Pituitary       Date:  2018-06       Impact factor: 4.107

Review 2.  Malignant transformation in non-functioning pituitary adenomas (pituitary carcinoma).

Authors:  Nèle Lenders; Ann McCormack
Journal:  Pituitary       Date:  2018-04       Impact factor: 4.107

3.  Pituitary Carcinoma Diagnosis and Survival Improvement, with Affordable Care Act Correlation: A SEER Database Study.

Authors:  Nathan J Wallace; Anand K Devaiah
Journal:  J Neurol Surg B Skull Base       Date:  2021-02-04

4.  Pituitary carcinoma recurrent to the lumbar intradural extramedullary space: case report.

Authors:  Paul M Arnold; Denesh Ratnasingam; Maura F O'Neil; Philip L Johnson
Journal:  J Spinal Cord Med       Date:  2012-02-08       Impact factor: 1.985

5.  Pituitary carcinoma with fourth ventricle metastasis: treatment by excision and Gamma-knife radiosurgery.

Authors:  Ki-Su Park; Jeong-Hyun Hwang; Sung-Kyoo Hwang; Sunzoo Kim; Seong-Hyun Park
Journal:  Pituitary       Date:  2014-12       Impact factor: 4.107

Review 6.  Aggressive Cushing's Disease: Molecular Pathology and Its Therapeutic Approach.

Authors:  Masaaki Yamamoto; Takahiro Nakao; Wataru Ogawa; Hidenori Fukuoka
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-16       Impact factor: 5.555

7.  Orbital metastasis of pituitary growth hormone secreting carcinoma causing lateral gaze palsy.

Authors:  Rohan R Lall; Stephen F Shafizadeh; Kyung-Hwa Lee; Qinwen Mao; Minesh Mehta; Jeffrey Raizer; Bernard R Bendok; James P Chandler
Journal:  Surg Neurol Int       Date:  2013-04-18

8.  ACTH-producing carcinoma of the pituitary with refractory Cushing's Disease and hepatic metastases: a case report and review of the literature.

Authors:  Scott N Pinchot; Rebecca Sippel; Herbert Chen
Journal:  World J Surg Oncol       Date:  2009-04-08       Impact factor: 2.754

9.  Prolactin Secreting Pituitary Carcinoma with Extracranial Spread Presenting with Pathological Fracture of Femur.

Authors:  Luis Rafael Moscote-Salazar; Guru Dutta Satyarthee; Willem Guillermo Calderon-Miranda; Jorge Aquino Matus; Alfonso Pacheco-Hernandez; Paulo Cesar Puac-Polanco; Amit Agrawal
Journal:  J Neurosci Rural Pract       Date:  2018 Jan-Mar

Review 10.  Malignant Prolactinoma With Liver Metastases Masquerading as Metastatic Gastrointestinal Stromal Tumor: A Case Report and Literature Review.

Authors:  A Ram Hong; Jee Hee Yoon; Hee Kyung Kim; Ho-Cheol Kang
Journal:  Front Endocrinol (Lausanne)       Date:  2020-07-14       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.